| Emily Catherine Parker, DO | |
|
3001 Havana St, Denver, CO 80238-4099 | |
| (720) 458-6825 | |
| Not Available |
| Full Name | Emily Catherine Parker |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 7 Years |
| Location | 3001 Havana St, Denver, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689115958 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | DR.0060983 (Colorado) | Secondary |
| 207Q00000X | Family Medicine | DR.0060983 (Colorado) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centura Health-st Anthony North Health Campus | Westminster, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Catholic Health Initiatives Colorado | 8022927342 | 998 |
News Archive
Cell>Point announced today that it has closed the Phase 2 portion of its Phase 2/3 trial of 99mTc-EC-G in evaluating patients with non-small cell lung cancer.
Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.
Tennessee-based hospital chain HCA on Friday began posting the prices of services for the uninsured at its hospitals in San Antonio and Austin, Texas, according to spokesperson Ed Fishbough, the Tennessean reports.
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican Congress of Cardiology. The findings create the possibility for patients to receive a pacemaker who otherwise could not afford one.
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
› Verified 9 days ago
| Entity Name | Catholic Health Initiatives Colorado |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356783351 PECOS PAC ID: 8022927342 Enrollment ID: O20031215000462 |
News Archive
Cell>Point announced today that it has closed the Phase 2 portion of its Phase 2/3 trial of 99mTc-EC-G in evaluating patients with non-small cell lung cancer.
Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.
Tennessee-based hospital chain HCA on Friday began posting the prices of services for the uninsured at its hospitals in San Antonio and Austin, Texas, according to spokesperson Ed Fishbough, the Tennessean reports.
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican Congress of Cardiology. The findings create the possibility for patients to receive a pacemaker who otherwise could not afford one.
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
› Verified 9 days ago
| Entity Name | Portercare Adventist Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760761928 PECOS PAC ID: 0941110886 Enrollment ID: O20090115000327 |
News Archive
Cell>Point announced today that it has closed the Phase 2 portion of its Phase 2/3 trial of 99mTc-EC-G in evaluating patients with non-small cell lung cancer.
Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.
Tennessee-based hospital chain HCA on Friday began posting the prices of services for the uninsured at its hospitals in San Antonio and Austin, Texas, according to spokesperson Ed Fishbough, the Tennessean reports.
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican Congress of Cardiology. The findings create the possibility for patients to receive a pacemaker who otherwise could not afford one.
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Emily Catherine Parker, DO Po Box 800022, Kansas City, MO 64180-0022 Ph: (800) 953-0104 | Emily Catherine Parker, DO 3001 Havana St, Denver, CO 80238-4099 Ph: (720) 458-6825 |
News Archive
Cell>Point announced today that it has closed the Phase 2 portion of its Phase 2/3 trial of 99mTc-EC-G in evaluating patients with non-small cell lung cancer.
Ever since the approval of Gleevec in 2001, a cancer-cell-specific drug used to treat chronic myelogenous leukemia (CML), the field of cancer therapeutics has been rushing full speed into the era of so-called "targeted" medicines.
Tennessee-based hospital chain HCA on Friday began posting the prices of services for the uninsured at its hospitals in San Antonio and Austin, Texas, according to spokesperson Ed Fishbough, the Tennessean reports.
Mexican doctors have safely reused donated pacemakers after sterilization, shows a study presented at the 30th Mexican Congress of Cardiology. The findings create the possibility for patients to receive a pacemaker who otherwise could not afford one.
Mayo researchers collaborating with investigators at the University of Iowa, University of Connecticut and New York University (NYU) have discovered a molecular mechanism that controls energy expenditure in muscles and helps determine body weight. Researchers say this could lead to a new medical approach in treating obesity.
› Verified 9 days ago
Dr. Huy C Ly, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 W 11th Ave Apt 517, Denver, CO 80204 Phone: 720-841-6706 | |
Claire Mcvay, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2130 Stout St, Denver, CO 80205 Phone: 303-293-2220 | |
Erica L Liesmaki, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4500 E 9th Ave, Ste #320, Denver, CO 80220 Phone: 303-322-0212 Fax: 303-322-0208 | |
Dr. Zachary John Anderson, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 90 Madison St, Suite 504, Denver, CO 80206 Phone: 720-524-1550 Fax: 720-524-1551 | |
George W Bock, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 777 Bannock St, Mc 7782, Denver, CO 80204 Phone: 303-436-6000 | |
Kristine Elizabeth Walsh, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2803 Roslyn St, Denver, CO 80238 Phone: 303-403-6300 Fax: 303-403-6315 | |
Dr. Caroline S Guillebaud, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 4720 Tejon St, Denver, CO 80211 Phone: 303-433-6563 Fax: 303-433-5614 |